Clinical Aspects and Precipitating Factors of Hepatic Encephalopathy Associated with Cirrhosis in a Cameroonian Population
- 1 Research Laboratory on Viral Hepatitis and Health Communication, Yaoundé, Cameroon
- 2 Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon
- 3 Gastroenterology Unit, Central Hospital, Yaoundé, Cameroon
- 4 Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon
- 5 Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon
- 6 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 7 Internal Medicine Unit Yaounde University Teaching Hospital, Yaoundé, Cameroon
- 8 Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon
- 9 Gastroenterology Unit, Central Hospital, Yaoundé, Cameroon
- 10 Faculty of Medicine and Pharmaceutical Sciences, The University of Douala, Douala, Cameroon
- 11 Research Laboratory on Viral Hepatitis and Health Communication, Yaoundé, Cameroon
Abstract
Background: Hepatic Encephalopathy (HE), a common complication of cirrhosis, is associated with a pejorative prognosis. This study aims to describe the clinical presentation, precipitating factors and outcome of HE. Methods: This was a cross-sectional multicenter inpatient study in cirrhotic patients admitted for HE in four tertiary hospitals in Yaoundé (Cameroon) from December 2016 to May 2017. The diagnosis of HE was based on West Haven clinical criteria. The diagnosis of cirrhosis was made using clinical and/or biological, endoscopic and/or ultrasonography signs. Results: A total of 53 patients with HE (mean age: 49.9 ± 18.9 years, 35 Males) were included. The frequency of hospital admission for HE was 4.9%. HE grade III was the most common (37.7%), followed by grades I and II (26.4% and 26.4%, respectively). Grade IV was present in 9.4% of cases. According to the Child-Pugh score, 72.1% of the patients were at stage C and 27.9% at stage B. The main precipitating factors found were: constipation (38.5%), hyponatremia (35.9%), hepatocellular carcinoma (HCC) (31.7%), herbal medicine (28.3%), hypokalemia (25.6%), gastrointestinal bleeding (22.6%) and ascitic fluid infection (spontaneous bacterial peritonitis) (13.8%). In 5.7% of cases, no factor was identified. Mortality rate during hospitalization was 45.3% and was significantly associated with stage III (RR = 11.1; 95% CI: 1.9 - 64.5; p = 0.003) and IV (RR = 24; 95% CI: 1.6 - 40.9; p = 0.01) of HE; Child-Pugh C score (RR = 15.2; 95% CI: 1.7 - 30.1; p = 0.003) and hypokalemia (RR = 12.2; 95% CI: 1.3 - 19; p = 0.01). Conclusion: HE is a common complication during cirrhosis with a poor prognosis. In the majority of cases, a precipitating factor could be determined.
- Weissenborn, K. (2019) Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles. Drugs, 79, S5-S9. https://doi.org/10.1007/s40265-018-1018-z
- Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K.D., et al. (2014) Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 60, 715-735. https://doi.org/10.1002/hep.27210
- Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K. and Blei, A.T. (2002) Hepatic Encephalopathy—Definition, Nomenclature, Diagnosis, and Quantification: Final Report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35, 716-721. https://doi.org/10.1053/jhep.2002.31250
- Muntaz, K., Ahmed Syed, U., Abid, S., Baig, N., Hamid, S. and Jafri, W. (2010) Precipitating Factors and The Outcome of Hepatic Encephalopathy in Liver Cirrhosis. Journal of the College of Physicians and Surgeons—Pakistan, 20, 514-518.
- Poudyal, N.S., Chaudhary, S., Kc, S., et al. (2019) Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis. Cureus, 11, e4363. https://doi.org/10.7759/cureus.4363
- Bustamante, J., Rimola, A., Ventura, P.J., Navasa, M., Cirera, I., Reggiardo, V. and Rodés, J. (1999) Prognostic Significance of Hepatic Encephalopathy in Patients with Cirrhosis. Journal of Hepatology, 30, 890-895.
- Ntagirabiri, R., Ntwari, W., Barasukana, P., Munezero, B. and Amani, M. (2016) Encéphalopathie hépatique: Facteurs précipitants, aspects cliniques et évolutifs à Bujumbura. Journal Africain d’Hépato-Gastroentérologie, 10, 89-93. https://doi.org/10.1007/s12157-016-0657-5
- García-Martínez, R., Simón-Talero, M. and Córdoba, J. (2011) Prognostic Assessment in Patients with Hepatic Encephalopathy. Disease Markers, 31, 171-179. https://doi.org/10.1155/2011/832031
- Bigna, J.J., Atsama, A., Asangbeh, L., Kenne, M., Noumegni, S., Ngo-Malabo, E., et al. (2017) Seroprevalence of Hepatitis B Virus Infection in Cameroon: A Systematic Review and Meta-Analysis. BMJ Open, 30, e015298. https://doi.org/10.1136/bmjopen-2016-015298
- Kowo, M.P., Andoulo, F.A., Ngek, L.T., Sizimboue, D.T., Ndam, A.N., Ondo, B.E., et al. (2019) Prevalence of Hepatitis C Virus and Associated Risk Factors among Inmates at New Bell Prison, Douala, Cameroon. Open Journal of Epidemiology, 9, 119-128. https://doi.org/10.4236/ojepi.2019.92011